Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
AboutMethodSourcesNewsletter
Insider tradingForm 4

RELMADA THERAPEUTICS, INC. (RLMD) Insider Trading

4 open-market trades reported since Sep 11, 2026: 4 purchases worth $1.67M and 0 sales worth $0.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Maged ShenoudaCFO2$844K0$0Sep 11, 2026
Sergio TraversaCEO2$828K0$0Sep 11, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

All trades

RLMD insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Sep 11Sep 9Maged ShenoudaCFOCFO▲ BUY120,2004.20$505K+15%Form 4 ↗
Sep 11Sep 9Sergio TraversaCEOCEO▲ BUY100,0004.18$418K+7.7%Form 4 ↗
Sep 11Sep 10Sergio TraversaCEOCEO▲ BUY100,0004.10$410K+7.1%Form 4 ↗
Sep 11Sep 10Maged ShenoudaCFOCFO▲ BUY79,8004.25$339K+8.7%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings